DENTSPLY SIRONA Inc
NASDAQ:XRAY
DENTSPLY SIRONA Inc
Cash & Cash Equivalents
DENTSPLY SIRONA Inc
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash & Cash Equivalents
$291m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
18%
|
|
Haemonetics Corp
NYSE:HAE
|
Cash & Cash Equivalents
$194m
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
Cooper Companies Inc
NYSE:COO
|
Cash & Cash Equivalents
$135.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
17%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash & Cash Equivalents
$865.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash & Cash Equivalents
$718.3m
|
CAGR 3-Years
118%
|
CAGR 5-Years
45%
|
CAGR 10-Years
45%
|
See Also
What is DENTSPLY SIRONA Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
291m
USD
Based on the financial report for Mar 31, 2024, DENTSPLY SIRONA Inc's Cash & Cash Equivalents amounts to 291m USD.
What is DENTSPLY SIRONA Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
18%
Over the last year, the Cash & Cash Equivalents growth was -8%. The average annual Cash & Cash Equivalents growth rates for DENTSPLY SIRONA Inc have been -3% over the past three years , 5% over the past five years , and 18% over the past ten years .